According to a report by Poder 360 on October 26th, Antonio Barra Torres, Director of Brazil's National Health Surveillance Agency (ANVISA), announced that the agency plans to hold a public consultation on the issue of e-cigarettes before the end of this year. This is part of their efforts to revise policies concerning the e-cigarette industry.
In an interview, Torres mentioned, "We always prioritize the public interest and strive to improve efficiency in our work as much as possible. Our next plan is to open up public consultations." He emphasized, "Consultations must allow enough time for broad public participation and should aim to complete this phase of work by the end of the current year.
Meanwhile, Congress has introduced legislation regarding e-cigarette regulations. During a public hearing held by the Social Affairs Committee on September 28th, proponents argued that a ban on the use of e-cigarettes would increase consumer risks, thus calling for regulation instead. On the other hand, opponents vehemently asserted that e-cigarettes increase the likelihood of individuals experimenting with traditional cigarettes and reiterated the health hazards associated with their usage.
Torres stated that the work of the Senate will not expedite the ANVISA approval process.
"No matter what happens, our work must be rooted in science," he said.
Torres reminded that the Brazilian National Health Surveillance Agency had banned e-cigarettes back in 2009. The agency's latest resolution, unanimously passed since July 2022, maintains the prohibition on the sale of these products.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
